DEVICE CATEGORY · PHO
Normothermic Preservation System For Transplantation Of Initially Unacceptable Donor Lungs
Preservation of donor lungs for transplantation.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Traferox Technologies, Inc. | PMA supplement | Oct 30, 2026 | FDA | |
| Traferox Technologies, Inc. | PMA supplement | Oct 30, 2026 | FDA | |
LungFX DeviceP240033/S001 | Lung Bioengineering, Inc. | PMA supplement | Oct 16, 2026 | FDA |
LungFX DeviceP240033/S002 | Lung Bioengineering, Inc. | PMA supplement | Oct 16, 2026 | FDA |
XPS with Steen Solution PerfusateP180014/S014 | Xvivo Perfusion, Inc. | PMA supplement | Sep 16, 2026 | FDA |
TorEx Lung Perfusion SystemP250025 | Traferox Technologies, Inc. | PMA approval | Jul 15, 2026 | FDA |
LungFX deviceP240033 | Lung Bioengineering, Inc. | PMA approval | Jun 22, 2026 | FDA |
XPS with Steen Solution PerfusateP180014/S013 | Xvivo Perfusion, Inc. | PMA supplement | Nov 25, 2025 | FDA |
| Xvivo Perfusion, Inc. | PMA approval | Apr 26, 2019 | FDA |
Source information
Follow the FDA links to view the original records.






